Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07459686
An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
Sponsor: Pfizer
View on ClinicalTrials.gov
Summary
A study to assess the safety and effectiveness of Velsipity Tablets 2 mg during long-term treatment (up to a maximum of 52 weeks) in patients with ulcerative colitis under actual medical practice.
Official title: Velsipity® Tablets 2 mg Special Investigation (Investigation on Long-Term Use in Patients With Ulcerative Colitis)
Key Details
Gender
All
Age Range
0 Years - Any
Study Type
OBSERVATIONAL
Enrollment
553
Start Date
2026-03-31
Completion Date
2029-01-29
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
DRUG
Velsipity
2 milligrams(mg) tablet as provided in real world practice